Promoting Optimal Treatment Choices in Neonates With Suspected Early-Onset Sepsis
Recruiting
Observational Study
Early-onset Sepsis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- Up to 3 Days
- Sex
- Any
- Study type
- Observational
- Participants needed
- 55,000 (estimated)
- Sponsor
- Franciscus Gasthuis · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In this study, three neonatal evidence-based antibiotic stewardship strategies will be implemented in Dutch hospitals. These include the early-onset sepsis (EOS) calculator, procalcitonin (PCT)-guided therapy, and IV-to-oral switch therapy. These strategies have been proven to be effective and safe and are already applied in several Dutch hospitals. However, this is not the case for all hospitals,…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Neonates born at 34 weeks of gestation or later
* 0-3 days old
Exclusion Criteria:
* stillborn neonates
Contacts
Liesanne E. J. Van Veen, MD
+31628138839
CONTACT